KRAS and neoplasm: Recent descriptions show that the mutant K-RAS protein presents two possible modifications in the GLY12 amino acid by CYS12 or ASP12 that alter their behavior which, compared to the function of the native protein, is maintained in a permanently active state that causes neoplasias related primarily to colorectal and lung cancer [62].